This site uses cookies to enhance your experience. By continuing to browse you accept our Cookie Policy.
Gloved hands drawing liquid from a vial into a syringe in a clinical setting

INSIGHTS

11 May 2026

Europe Leads mRNA's Leap Beyond Vaccines

A 325-trial study shows Europe's mRNA pipeline is built on deep international collaboration and a late-stage clinical focus

European Medicines Agency building sign with EMA logo and street address

REGULATORY

7 May 2026

mRNA Steps Up: Europe Eyes a New Era for Flu Vaccines

Moderna's mRNA flu vaccine clears a key EMA hurdle, backed by trial data showing it outperforms standard flu shots in older adults

Masked healthcare worker administering a vaccine injection

PARTNERSHIPS

5 May 2026

Ethris and DZIF Ink Massive Vaccine Deal

Germany strengthens its biotech sovereignty as Ethris and DZIF partner to develop next-gen mRNA vaccines targeting bacteria and parasites&...

Masked healthcare worker drawing vaccine from a vial into a syringe

MARKET TRENDS

30 Apr 2026

Europe Bets Big on mRNA Beyond COVID

A 557-trial analysis shows Europe at the centre of mRNA medicine's shift from COVID vaccines toward cancer and rare disease treatments

Speaker at European Parliament lectern with member state flags

MARKET TRENDS

16 Apr 2026

Brussels Bets Big on Homegrown mRNA

The EU’s new Critical Medicines Act prioritizes local mRNA production over cheap imports to secure a more resilient medical future

IRCM building exterior with modern glass facade

MARKET TRENDS

2 Apr 2026

mRNA's Invisible Engine Is Now a $565M Market

Lipid nanoparticle manufacturing reaches $565m in 2026, driven by mRNA cancer vaccines and gene therapy pipelines

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.